Psilocybin as a New Approach to Treat Depression and Anxiety in the Context of Life-Threatening Diseases—A Systematic Review and Meta-Analysis of Clinical Trials

The experimental effects of psilocybin on symptoms of anxiety and depression: A meta-analysis

(2020) Simon B. Goldberg et al.   PSYCHIATRY RESEARCH

The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act

(2018) Matthew W. Johnson et al.   NEUROPHARMACOLOGY

Treatment resistant depression: A multi-scale, systems biology approach

(2018) Huda Akil et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Psilocybin with psychological support improves emotional face recognition in treatment-resistant depression

(2017) J. B. Stroud et al.   PSYCHOPHARMACOLOGY

Psilocybin with psychological support for treatment-resistant depression: six-month follow-up

(2017) R. L. Carhart-Harris et al.   PSYCHOPHARMACOLOGY

Psychedelics as Medicines: An Emerging New Paradigm

(2016) DE Nichols et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial

(2016) Roland R Griffiths et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial

(2016) Stephen Ross et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Association of Breast Cancer Knowledge With Receipt of Guideline-Recommended Breast Cancer Treatment

(2016) Rachel A. Freedman et al.   Journal of Oncology Practice

Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers

(2015) Rainer Kraehenmann et al.   BIOLOGICAL PSYCHIATRY

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2013) David Moher   ANNALS OF INTERNAL MEDICINE

Psilocybin – Summary of knowledge and new perspectives

(2013) Filip Tylš et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Treatment-resistant depression: Definitions, review of the evidence, and algorithmic approach

(2013) Roger S. McIntyre et al.   JOURNAL OF AFFECTIVE DISORDERS

Prediction of Psilocybin Response in Healthy Volunteers

(2012) Erich Studerus et al.   PLoS One

Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin

(2012) R. L. Carhart-Harris et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Measures of anxiety: State-Trait Anxiety Inventory (STAI), Beck Anxiety Inventory (BAI), and Hospital Anxiety and Depression Scale-Anxiety (HADS-A)

(2011) Laura J. Julian   ARTHRITIS CARE & RESEARCH

Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer

(2010) Charles S. Grob et al.   ARCHIVES OF GENERAL PSYCHIATRY

Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies

(2010) Erich Studerus et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Depression and cancer mortality: a meta-analysis

(2010) M. Pinquart et al.   PSYCHOLOGICAL MEDICINE

Human hallucinogen research: guidelines for safety

(2008) MW Johnson et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Cognitive therapy versus medication for depression: treatment outcomes and neural mechanisms

(2008) Robert J. DeRubeis et al.   NATURE REVIEWS NEUROSCIENCE